Ethyl chloroformate → 4-Fluoro-2-{2-fluoro-4-[(3-oxopiperazin-1-yl)carbonyl]phenoxy}-5-ethylphenyl ethyl carbonate
反応式
[CH2:1]([C:3]1[C:25]([F:26])=[CH:24][C:6]([O:7][C:8]2[CH:22]=[CH:21][C:11]([C:12]([N:14]3[CH2:19][CH2:18][NH:17][C:16](=[O:20])[CH2:15]3)=[O:13])=[CH:10][C:9]=2[F:23])=[C:5]([O:27][CH3:28])[CH:4]=1)[CH3:2].[OH-:29].[K+].[CH2:31]([O:33]C(Cl)=O)[CH3:32]>C(#N)C>[C:28](=[O:29])([O:33][CH2:31][CH3:32])[O:27][C:5]1[CH:4]=[C:3]([CH2:1][CH3:2])[C:25]([F:26])=[CH:24][C:6]=1[O:7][C:8]1[CH:22]=[CH:21][C:11]([C:12]([N:14]2[CH2:19][CH2:18][NH:17][C:16](=[O:20])[CH2:15]2)=[O:13])=[CH:10][C:9]=1[F:23]参加物
5
実験手順
To a solution of 4-[4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluorobenzoyl]piperazin-2-one (20 mg, 0.053 mmol; which may be prepared as described in D3) in acetonitrile (550 μL) was added KOH (3 mg, 0.053 mmol) followed by ethylchlorocarbonate (6 μL, 0.058 mmol). After 1 hour at room temperature, the mixture was quenched with water. The aqueous layer was extracted twice with ethyl acetate. The organic phase was dried over sodium sulphate, filtered and concentrated under vacuum. The residue was purified by preparative thin layer chromatography on silica gel, using dichloromethane/methanol (95:5) as eluent. The title product was obtained as a white solid (11 mg, 46%).
後処理
- customthe mixture was quenched with water
- extractionThe aqueous layer was extracted twice with ethyl acetate
- dry with materialThe organic phase was dried over sodium sulphate
- filtrationfiltered
- concentrationconcentrated under vacuum
- customThe residue was purified by preparative thin layer chromatography on silica gel
出典と根拠
- ORDレコード
- ord-4e9787902e424e06ab405efcccdf09a7
- 出典データセット
- uspto-grants-2013_02
- 特許番号
- US08383621B2
反応ノート
読み込み中…